Cited by 371Pancreatic function and diabetesDiabetes Treatment and ManagementNeuropeptides and Animal Physiology

The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.

Entero-Insular Axis

Unger, Roger H.·1969·Archives of Internal Medicine

DOI 10.1001/archinte.1969.00300130043007

Open this paper in CoChat — free account

Abstract

Evidence for an entero-insular axis is based upon studies showing that amino acids as well as glucose cause a greater and earlier release of islet cell hormones when administered via the gastrointestinal tract than occurs with comparable elevations in the plasma concentrations of the nutrients given intravenously. The ability of several gastrointestinal hormones to elicit immediate augmentation of insulin and glucagon secretion has been established. Gastrin, secretin, and pancreozymin in dogs all produce an immediate rise of insulin to a peak one minute after injection, but the response to gastrin is quantitatively trivial, while that to secretin is modest. However, pancreozymin elicits substantial release of both insulin and glucagon, and augments the insulinogenic and glucagonogenic effects of amino acids. The physiologic implications of such studies are considered.

Integrity signals

Registry

Crossref · 10.1001/archinte.1969.00300130043007

Cites

20 of 20 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Immunoassay of endogenous plasma insulin in man
Yalow, R. S., & Berson, S. A. (1960) · Journal of Clinical Investigation · doi:10.1172/jci104130 · Cited by 3,041
Plasma Insulin Responses to Oral and Intravenous Glucose: Studies in Normal and Diabetic Subjects*
Perley, M. J., & Kipnis, D. M. (1967) · Journal of Clinical Investigation · doi:10.1172/jci105685 · Cited by 917
Plasma Insulin Response to Oral and Intravenous Glucose Administration1
ELRICK, H., STIMMLER, L., HLAD, C. J., & ARAI, Y. (1964) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-24-10-1076 · Cited by 857
New Interpretation of Oral Glucose Tolerance
Mcintyre, N., Holdsworth, C. D., & Turner, D. S. (1964) · The Lancet · doi:10.1016/s0140-6736(64)90011-x · Cited by 738
The Effects of Secretin, Pancreozymin, and Gastrin on Insulin and Glucagon Secretion in Anesthetized Dogs *
Unger, R. H., Ketterer, H., Dupré, J., & Eisentraut, A. M. (1967) · Journal of Clinical Investigation · doi:10.1172/jci105565 · Cited by 337
Self-citation
Characterization of the responses of circulating glucagon-like immunoreactivity to intraduodenal and intravenous administration of glucose
Unger, R. H., Ohneda, A., Valverde, I., Eisentraut, A. M., & Exton, J. H. (1968) · Journal of Clinical Investigation · doi:10.1172/jci105714 · Cited by 296
Self-citation
GLUCAGON ANTIBODIES AND AN IMMUNOASSAY FOR GLUCAGON*
Unger, R. H., Eisentraut, A. M., McCall, M. S., & Madison, L. L. (1961) · Journal of Clinical Investigation · doi:10.1172/jci104357 · Cited by 285
Self-citation
On the treatment of Diabetus mellitus by acid extract of Duodenal Mucous Membrane
Moore, B., Edie, E. S., & Abram, J. H. (1906) · Biochemical Journal · doi:10.1042/bj0010028 · Cited by 279
Physiological Determination of Release of Secretin and Pancreozymin From Intestine of Dogs With Transplanted Pancreas
Wang, C. C., & Grossman, M. I. (1951) · American Journal of Physiology-Legacy Content · doi:10.1152/ajplegacy.1951.164.2.527 · Cited by 230
Characterization of response of circulating glucagon to intraduodenal and intravenous administration of amino acids
Ohneda, A., Parada, E., Eisentraut, A. M., & Unger, R. H. (1968) · Journal of Clinical Investigation · doi:10.1172/jci105916 · Cited by 201
Self-citation

Show all 20 references

Sorted by citations

Reduced incretin effect in Type 2 (non-insulin dependent) diabetes
Nauck, M., Stöckmann, F., Ebert, R., & Creutzfeldt, W. (1986) · Diabetologia · doi:10.1007/bf02427280 · Cited by 1,307
Degradation of glucose-dependent insulinotropic polypeptide and truncated glucagon-like peptide 1 in vitro and in vivo by dipeptidyl peptidase IV.
Kieffer, T. J., McIntosh, C. H., & Pederson, R. A. (1995) · Endocrinology · doi:10.1210/endo.136.8.7628397 · Cited by 1,124
The Glucagon-Like Peptides
Kieffer, T. J., & Habener, J. F. (1999) · Endocrine Reviews · doi:10.1210/edrv.20.6.0385 · Cited by 1,062
Expression cloning of the pancreatic beta cell receptor for the gluco-incretin hormone glucagon-like peptide 1.
Thorens, B. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.18.8641 · Cited by 906
Insulinotropin: glucagon-like peptide I (7-37) co-encoded in the glucagon gene is a potent stimulator of insulin release in the perfused rat pancreas.
Mojsov, S., Weir, G. C., & Habener, J. F. (1987) · Journal of Clinical Investigation · doi:10.1172/jci112855 · Cited by 889
Incretin effects of increasing glucose loads in man calculated from venous insulin and C-peptide responses
NAUCK, M. A., HOMBERGER, E., SIEGEL, E. G., ALLEN, R. C., EATON, R. P., EBERT, R., & CREUTZFELDT, W. (1986) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-63-2-492 · Cited by 874
The incretin concept today
Creutzfeldt, W. (1979) · Diabetologia · doi:10.1007/bf01225454 · Cited by 731
Role of incretin hormones in the regulation of insulin secretion in diabetic and nondiabetic humans
Holst, J. J., & Gromada, J. (2004) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00545.2003 · Cited by 611
Coffee acutely modifies gastrointestinal hormone secretion and glucose tolerance in humans: glycemic effects of chlorogenic acid and caffeine
Johnston, K. L., Clifford, M. N., & Morgan, L. M. (2003) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/78.4.728 · Cited by 590
Ghrelin, CCK, GLP-1, and PYY(3–36): Secretory Controls and Physiological Roles in Eating and Glycemia in Health, Obesity, and After RYGB
Steinert, R. E., Feinle-Bisset, C., Asarian, L., Horowitz, M., Beglinger, C., & Geary, N. (2017) · Physiological Reviews · doi:10.1152/physrev.00031.2014 · Cited by 578
Cloning and Functional Expression of the Human Islet GLP-1 Receptor: Demonstration That Exendin-4 Is an Agonist and Exendin-(9–39) an Antagonist of the Receptor
Thorens, B., Porret, A., Bühler, L. H., Deng, S., Morel, P., & Widmann, C. (1993) · Diabetes · doi:10.2337/diab.42.11.1678 · Cited by 555
Cell and Molecular Biology of the Incretin Hormones Glucagon-Like Peptide-I and Glucose-Dependent Insulin Releasing Polypeptide
Fehmann, H. C., Göke, R., & Göke, B. (1995) · Endocrine Reviews · doi:10.1210/edrv-16-3-390 · Cited by 529
International Union of Pharmacology. XXXV. The Glucagon Receptor Family
Mayo, K. E., Miller, L. J., BATAILLE, D., Dalle, S., Göke, B., Thorens, B., & Drucker, D. J. (2003) · Pharmacological Reviews · doi:10.1124/pr.55.1.6 · Cited by 514
The incretin effect in healthy individuals and those with type 2 diabetes: Physiology, pathophysiology, and response to therapeutic interventions
Nauck, M. A., & Meier, J. J. (2016) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(15)00482-9 · Cited by 503
Glucose intolerance caused by a defect in the entero-insular axis: A study in gastric inhibitory polypeptide receptor knockout mice
Miyawaki, K., Yamada, Y., Yano, H., Niwa, H., Ban, N., Ihara, Y., Kubota, A., Fujimoto, S., Kajikawa, M., Kuroe, A., et al. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.26.14843 · Cited by 454
Tissue-specific expression of the human receptor for glucagon-like peptide-I: Brain, heart and pancreatic forms have the same deduced amino acid sequences
Wei, Y., & Mojsov, S. (1995) · FEBS Letters · doi:10.1016/0014-5793(94)01430-9 · Cited by 450
Insulinotropic hormone glucagon-like peptide-I(7-37) stimulation of proinsulin gene expression and proinsulin biosynthesis in insulinoma beta TC-1 cells
Fehmann, H. C., & Habener, J. F. (1992) · Endocrinology · doi:10.1210/endo.130.1.1309325 · Cited by 339
Identification and Actions of Gastric Inhibitory Polypeptide
Brown, J. C., Dryburgh, J. R., ROSS, S. A., & DUPRÉ, J. (1975) · Elsevier eBooks · doi:10.1016/b978-0-12-571131-9.50017-7 · Cited by 336
Double Incretin Receptor Knockout (DIRKO) Mice Reveal an Essential Role for the Enteroinsular Axis in Transducing the Glucoregulatory Actions of DPP-IV Inhibitors
Hansotia, T., Baggio, L. L., Delmeire, D., Hinke, S. A., Yamada, Y., Tsukiyama, K., Seino, Y., Holst, J. J., Schuit, F., & Drucker, D. J. (2004) · Diabetes · doi:10.2337/diabetes.53.5.1326 · Cited by 309
The insulinotropic actions of glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (7–37) in normal and diabetic subjects
Elahi, D., McAloon-Dyke, M., Fukagawa, N. K., Meneilly, G. S., Sclater, A. L., Minaker, K. L., Habener, J. F., & Andersen, D. K. (1994) · Regulatory Peptides · doi:10.1016/0167-0115(94)90136-8 · Cited by 308
Extrapancreatic incretin receptors modulate glucose homeostasis, body weight, and energy expenditure
Hansotia, T., Maida, A., Flock, G., Yamada, Y., Tsukiyama, K., Seino, Y., & Drucker, D. J. (2007) · Journal of Clinical Investigation · doi:10.1172/jci25483 · Cited by 290
Analysis of upstream glucokinase promoter activity in transgenic mice and identification of glucokinase in rare neuroendocrine cells in the brain and gut.
Jetton, T. L., Liang, Y. T., Pettepher, C. C., Zimmerman, E. C., Cox, F., Horvath, K., Matschinsky, F. M., & Magnuson, M. A. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)41910-7 · Cited by 279
New developments in the incretin concept
Creutzfeldt, W., & Ebert, R. (1985) · Diabetologia · doi:10.1007/bf00281990 · Cited by 277
Glucose metabolism and hyperglycemia
Giugliano, D., Ceriello, A., & Esposito, K. (2008) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/87.1.217s · Cited by 284
The importance of first-phase insulin secretion: implications for the therapy of type 2 diabetes mellitus
Prato, S. D., & Tiengo, A. (2001) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.198 · Cited by 241
The Effect of Liraglutide, a Long-Acting Glucagon-Like Peptide 1 Derivative, on Glycemic Control, Body Composition, and 24-h Energy Expenditure in Patients With Type 2 Diabetes
Harder, H., Nielsen, L., Thi, T. D. T., & Astrup, A. V. (2004) · Diabetes Care · doi:10.2337/diacare.27.8.1915 · Cited by 230
Long-Term Treatment With the Dipeptidyl Peptidase IV Inhibitor P32/98 Causes Sustained Improvements in Glucose Tolerance, Insulin Sensitivity, Hyperinsulinemia, and β-Cell Glucose Responsiveness in VDF (fa/fa) Zucker Rats
Pospisilik, J. A., Stafford, S. G., Demuth, H.-U., Brownsey, R. W., Parkhouse, W. S., Finegood, D. T., McIntosh, C. H. S., & Pederson, R. A. (2002) · Diabetes · doi:10.2337/diabetes.51.4.943 · Cited by 232
Initial splanchnic extraction of ingested glucose in normal man
Radziuk, J., McDonald, T. J., Rubenstein, D., & Dupre, J. (1978) · Metabolism · doi:10.1016/0026-0495(78)90003-3 · Cited by 207
Vagal hepatopancreatic reflex effect evoked by intraportal appearance of tGLP-1
Nakabayashi, H., NISHIZAWA, M., Nakagawa, A., Takeda, R., & Niijima, A. (1996) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1996.271.5.e808 · Cited by 203
Narrative Review: Effect of Bariatric Surgery on Type 2 Diabetes Mellitus
Vetter, M. L., Cardillo, S., Rickels, M. R., & Iqbal, N. (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-150-2-200901200-00007 · Cited by 193
Glucagon-like peptide-1 is a physiological incretin in rat.
Wang, Z., Wang, R. M., Owji, A. A., Smith, D. M., Ghatei, M. A., & Bloom, S. R. (1995) · Journal of Clinical Investigation · doi:10.1172/jci117671 · Cited by 185
Changes in Insulin Resistance Following Bariatric Surgery: Role of Caloric Restriction and Weight Loss
Gumbs, A. A., Modlin, I. M., & Ballantyne, G. H. (2005) · Obesity Surgery · doi:10.1381/0960892053723367 · Cited by 188
Physiology of incretins (GIP and GLP-1) and abnormalities in type 2 diabetes
Gautier, J. F., Choukem, S. P., & Girard, J. R. (2008) · Diabetes & Metabolism · doi:10.1016/s1262-3636(08)73397-4 · Cited by 186
GIP and GLP-1 as incretin hormones: lessons from single and double incretin receptor knockout mice
Hansotia, T., & Drucker, D. J. (2004) · Regulatory Peptides · doi:10.1016/j.regpep.2004.07.019 · Cited by 187
Gut hormones and diabetes mellitus
Creutzfeldt, W., & Nauck, M. (1992) · Diabetes/Metabolism Reviews · doi:10.1002/dmr.5610080206 · Cited by 176
First-phase insulin secretion: does it exist in real life? Considerations on shape and function
Caumo, A., & Luzi, L. (2004) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00139.2003 · Cited by 181
Receptors and effects of gut hormones in three osteoblastic cell lines
Pacheco-Pantoja, E. L., Ranganath, L. R., Gallagher, J. A., Wilson, P. J., & Fraser, W. D. (2011) · BMC Physiology · doi:10.1186/1472-6793-11-12 · Cited by 175
Chapter 15 Glucose‐Dependent Insulinotropic Polypeptide (Gastric Inhibitory Polypeptide; GIP)
McIntosh, C. H. S., Widenmaier, S. B., & Kim, S. (2009) · Vitamins and hormones · doi:10.1016/s0083-6729(08)00615-8 · Cited by 173
The Effect of Gastrin on Basal- and Glucose-Stimulated Insulin Secretion in Man
Rehfeld, J. F., & STADIL, F. (1973) · Journal of Clinical Investigation · doi:10.1172/jci107315 · Cited by 165
Biological actions of the incretins GIP and GLP-1 and therapeutic perspectives in patients with type 2 diabetes
Gautier, J. F., Fetita, S., Sobngwi, E., & Salaun-Martin, C. (2005) · Diabetes & Metabolism · doi:10.1016/s1262-3636(07)70190-8 · Cited by 164
Physiologic relevance of heterogeneity in the pancreatic beta-cell population
PIPELEERS, D. G., Kiekens, R., Ling, Z., Wilikens, A., & Schuit, F. C. (1994) · Diabetologia · doi:10.1007/bf00400827 · Cited by 150
Postprandial stimulation of insulin release by glucose-dependent insulinotropic polypeptide (GIP). Effect of a specific glucose-dependent insulinotropic polypeptide receptor antagonist in the rat.
Tseng, C., Kieffer, T. J., Jarboe, L. A., Usdin, T. B., & Wolfe, M. M. (1996) · Journal of Clinical Investigation · doi:10.1172/jci119060 · Cited by 149
Erythromycin Antagonizes the Deceleration of Gastric Emptying by Glucagon-Like Peptide 1 and Unmasks Its Insulinotropic Effect in Healthy Subjects
Meier, J. J., Kemmeries, G., Holst, J. J., & Nauck, M. A. (2005) · Diabetes · doi:10.2337/diabetes.54.7.2212 · Cited by 146
Glucagon-like peptide-1: a major regulator of pancreatic beta-cell function
Perfetti, R., & Merkel, P. A. (2000) · European Journal of Endocrinology · doi:10.1530/eje.0.1430717 · Cited by 145
Targeting the glucagon receptor family for diabetes and obesity therapy
Cho, Y. M., Merchant, C. E., & Kieffer, T. J. (2012) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2012.05.009 · Cited by 144
Carbohydrate Metabolism and Its Disorders
Kaneko, J. J. (1980) · Elsevier eBooks · doi:10.1016/b978-0-12-396350-5.50006-1 · Cited by 142
The Enteroinsular Axis and the Recovery from Type 2 Diabetes after Bariatric Surgery
Patriti, A., Facchiano, E., Sanna, A., Gullà, N., & Donini, A. (2004) · Obesity Surgery · doi:10.1381/0960892041590818 · Cited by 139
Changes in Insulin Resistance Following Bariatric Surgery and the Adipoinsular Axis: Role of the Adipocytokines, Leptin, Adiponectin and Resistin
Ballantyne, G. H., Gumbs, A. A., & Modlin, I. M. (2005) · Obesity Surgery · doi:10.1381/0960892053923789 · Cited by 131
Lipids and Lipid Metabolism
Masoro, E. J. (1977) · Annual Review of Physiology · doi:10.1146/annurev.ph.39.030177.001505 · Cited by 130
Glucose-dependent insulinotropic polypeptide receptor null mice exhibit compensatory changes in the enteroinsular axis
Pamir, N., Lynn, F. C., Buchan, A. M. J., Ehses, J., Hinke, S. A., Pospisilik, J. A., Miyawaki, K., Yamada, Y., Seino, Y., McIntosh, C. H. S., et al. (2003) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00270.2002 · Cited by 126
Preservation of incretin activity after removal of gastric inhibitory polypeptide (GIP) from rat gut extracts by immunoadsorption
Ebert, R., Unger, H., & Creutzfeldt, W. (1983) · Diabetologia · doi:10.1007/bf00257346 · Cited by 120
Pathophysiology of Diabetes Mellitus
Sherwin, R., & Felig, P. (1978) · Medical Clinics of North America · doi:10.1016/s0025-7125(16)31766-7 · Cited by 121
Incretin hormone mimetics and analogues in diabetes therapeutics
Green, B. D., & Flatt, P. R. (2007) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2007.09.003 · Cited by 115
Carbohydrate Homeostasis
Levine, R., & Haft, D. E. (1970) · New England Journal of Medicine · doi:10.1056/nejm197007232830405 · Cited by 114
Structurally Modified Analogues of Glucagon-Like Peptide-1 (GLP-1) and Glucose-Dependent Insulinotropic Polypeptide (GIP) As Future Antidiabetic Agents
Green, B., Gault, V., O'Harte, F., & Flatt, P. (2004) · Current Pharmaceutical Design · doi:10.2174/1381612043382774 · Cited by 111
Neural regulation of the endocrine pancreas
Brunicardi, F. C., Shavelle, D. M., & Andersen, D. K. (1995) · International Journal of Pancreatology · doi:10.1007/bf02784941 · Cited by 108
Therapeutic potential for GIP receptor agonists and antagonists
Irwin, N., & Flatt, P. R. (2009) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2009.03.001 · Cited by 105
Metformin Effects on Dipeptidylpeptidase IV Degradation of Glucagon-like Peptide-1
Hinke, S. A., Kühn‐Wache, K., Hoffmann, T., Pederson, R. A., McIntosh, C. H. S., & Demuth, H. (2002) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2002.6607 · Cited by 103
Effects of oral fructose and glucose on plasma GLP-1 and appetite in normal subjects
Kong, M., Chapman, I. M., Goble, E., Wishart, J. M., Wittert, G., Morris, H. A., & Horowitz, M. (1999) · Peptides · doi:10.1016/s0196-9781(99)00006-6 · Cited by 101
The [pre-] history of the incretin concept
Creutzfeldt, W. (2004) · Regulatory Peptides · doi:10.1016/j.regpep.2004.08.004 · Cited by 104
Improved glucose tolerance in rats treated with the dipeptidyl peptidase IV (CD26) inhibitor Ile-thiazolidide
Pauly, R. P., Demuth, H., Rosche, F., Schmidt, J., White, H. A., Lynn, F. C., McIntosh, C. H. S., & Pederson, R. A. (1999) · Metabolism · doi:10.1016/s0026-0495(99)90090-2 · Cited by 103
The Origin and Understanding of the Incretin Concept
Rehfeld, J. F. (2018) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00387 · Cited by 102
Glucagon-like peptide-1 evokes action potentials and increases cytosolic Ca2+ in rat nodose ganglion neurons
Kakei, M., Yada, T., Nakagawa, A., & Nakabayashi, H. (2002) · Autonomic Neuroscience · doi:10.1016/s1566-0702(02)00182-0 · Cited by 109
Gastric Inhibitory Polypeptide Release after Oral Glucose: Relationship to Glucose Intolerance, Diabetes Mellitus, and Obesity
Salera, M., Giacomoni, P., Pironi, L., Cornia, G. L., Capelli, M., Marini, A. M., Benfenati, F., Miglioli, M., & Barbara, L. (1982) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-55-2-329 · Cited by 101
Glucose-dependent insulinotropic polypeptide (GIP)
Müller, T. D., Adriaenssens, A. E., Ahrén, B., Blüher, M., Birkenfeld, A. L., Campbell, J. E., Coghlan, M. P., D’Alessio, D. D., Deacon, C. F., DelPrato, S., et al. (2025) · Molecular Metabolism · doi:10.1016/j.molmet.2025.102118 · Cited by 103
K-cells and Glucose-Dependent Insulinotropic Polypeptide in Health and Disease
Cho, Y. M., & Kieffer, T. J. (2010) · Vitamins and hormones · doi:10.1016/b978-0-12-381517-0.00004-7 · Cited by 98
Oral glucose is the prime elicitor of preabsorptive insulin secretion
Grill, H. J., Berridge, K. C., & Ganster, D. J. (1984) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.1984.246.1.r88 · Cited by 92
Gastrointestinal peptides and insulin secretion
Ebert, R., & Creutzfeldt, W. (1987) · Diabetes/Metabolism Reviews · doi:10.1002/dmr.5610030101 · Cited by 92
Glucagon‐like peptide‐1(7–36) amide is a new incretin/enterogastrone candidate
Göke, R., Fehmann, H. C., & Göke, B. (1991) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.1991.tb01802.x · Cited by 89
Dipeptidyl peptidase IV (DPP IV) and related molecules in type 2 diabetes
Flatt, P. R. (2008) · Frontiers in bioscience · doi:10.2741/2956 · Cited by 85
Glucose-Dependent Insulinotropic Polypeptide Confers Early Phase Insulin Release to Oral Glucose in Rats: Demonstration by a Receptor Antagonist
Lewis, J. T., Dayanandan, B., Habener, J. F., & Kieffer, T. J. (2000) · Endocrinology · doi:10.1210/endo.141.10.7750 · Cited by 87
The milieu interieur and the islets of Langerhans
Unger, R. H. (1981) · Diabetologia · doi:10.1007/bf00253809 · Cited by 84
Self-citation
Physiology and Emerging Biochemistry of the Glucagon-Like Peptide-1 Receptor
Willard, F. S., & Sloop, K. W. (2012) · Experimental Diabetes Research · doi:10.1155/2012/470851 · Cited by 84
Glucagon-Like Peptide-1, But Not Glucose-Dependent Insulinotropic Peptide, Regulates Fasting Glycemia and Nonenteral Glucose Clearance in Mice
Baggio, L. L., Kieffer, T. J., & Drucker, D. J. (2000) · Endocrinology · doi:10.1210/endo.141.10.7720 · Cited by 78
Metabolic Regulation of Plasma Insulin Levels in Cattle
McAtee, J. W., & Trenkle, A. (1971) · Journal of Animal Science · doi:10.2527/jas1971.332438x · Cited by 79
Immunocytochemical evidence for a paracrine interaction between GIP and GLP-1-producing cells in canine small intestine
Damholt, A. B., Kofod, H., & Buchan, A. M. J. (1999) · Cell and Tissue Research · doi:10.1007/s004419900093 · Cited by 78
Secretion of incretin hormones and the insulinotropic effect of gastric inhibitory polypeptide in women with a history of gestational diabetes
Meier, J. J., Gallwitz, B., Askenas, M., Vollmer, K., Deacon, C. F., Holst, J. J., Schmidt, W. E., & Nauck, M. A. (2005) · Diabetologia · doi:10.1007/s00125-005-1863-7 · Cited by 77
Prolonged Successful Therapy for Hyperinsulinaemic Hypoglycaemia after Gastric Bypass: The Pathophysiological Role of GLP1 and Its Response to a Somatostatin Analogue
Myint, K. S., Greenfield, J. R., Farooqi, I. S., Henning, E., Holst, J. J., & Finer, N. (2012) · European Journal of Endocrinology · doi:10.1530/eje-11-1065 · Cited by 77
Gastric inhibitory polypeptide modulates adiposity and fat oxidation under diminished insulin action
Zhou, H., Yamada, Y., Tsukiyama, K., Miyawaki, K., Hosokawa, M., Nagashima, K., Toyoda, K., Naitoh, R., Mizunoya, W., Fushiki, T., et al. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.07.164 · Cited by 77
Incretin hormones - an update
Holst, J. J., & Ørskov, C. (2001) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.1080/clb.61.234.75.85 · Cited by 77
Glucagon, gastrin, and carcinoid tumors of the duodenum, pancreas, and stomach: Polypeptide “apudomas” of the foregut
Friesen, S. R., Hermreck, A. S., & Mantz, F. A. (1974) · The American Journal of Surgery · doi:10.1016/0002-9610(74)90017-8 · Cited by 71
The Insulinotropic Effect of Endogenous Gastric Inhibitory Polypeptide in Normal Subjects
Crockett, S. E., Cataland, S., Falko, J. M., & Mazzaferri, E. L. (1976) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-42-6-1098 · Cited by 70
Metabolic Mechanisms in Obesity and Type 2 Diabetes: Insights from Bariatric/Metabolic Surgery
Cătoi, A. F., Pârvu, A. E., Mureșan, A., & Busetto, L. (2015) · Obesity Facts · doi:10.1159/000441259 · Cited by 69
Glucagon-like peptide-1(7–37)/(7–36)amide is a new incretin
Fehmann, H. C., Göke, R., & Göke, B. (1992) · Molecular and Cellular Endocrinology · doi:10.1016/0303-7207(92)90118-p · Cited by 65
Intraportal GLP-1 stimulates insulin secretion predominantly through the hepatoportal-pancreatic vagal reflex pathways
Nishizawa, M., Nakabayashi, H., Uehara, K., Nakagawa, A., Uchida, K., & Koya, D. (2013) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00565.2012 · Cited by 66
An extract of Gymnema sylvestre leaves and purified gymnemic acid inhibits glucose-stimulated gastric inhibitory peptide secretion in rats.
Fushiki, T., Kojima, A., Imoto, T., Inoue, K., & Sugimoto, E. (1992) · Journal of NutriLife · doi:10.1093/jn/122.12.2367 · Cited by 73
Incretin hormone secretion in women with polycystic ovary syndrome: roles of obesity, insulin sensitivity, and treatment with metformin
Svendsen, P. F., Nilas, L., Madsbad, S., & Holst, J. J. (2009) · Metabolism · doi:10.1016/j.metabol.2008.11.009 · Cited by 64
Immune recognition and response to the intestinal microbiome in type 1 diabetes
Paun, A., Yau, C., & Danska, J. S. (2016) · Journal of Autoimmunity · doi:10.1016/j.jaut.2016.02.004 · Cited by 67
The gastrointestinal stimulus to insulin release
Kraegen, E. W., Chisholm, D. J., Young, J. D., & Lazarus, L. (1970) · Journal of Clinical Investigation · doi:10.1172/jci106262 · Cited by 61
Suppressive effect of secretin upon pancreatic alpha cell function
Santeusanio, F., Faloona, G. R., & Unger, R. H. (1972) · Journal of Clinical Investigation · doi:10.1172/jci106975 · Cited by 60
Self-citation
Radioimmunoassay of Plasma Hormones: Review of Plasma Insulin in Ruminants
Trenkle, A. H. (1972) · Journal of Dairy Science · doi:10.3168/jds.s0022-0302(72)85648-0 · Cited by 59
Physiological Role of Cholecystokinin in Meal-Induced Insulin Secretion in Conscious Rats: Studies With L 364718, A Specific Inhibitor of CCK-Receptor Binding
Rossetti, L., Shulman, G. I., & Zawalich, W. S. (1987) · Diabetes · doi:10.2337/diab.36.10.1212 · Cited by 57
Elevated Plasma Glucose-Dependent Insulinotropic Polypeptide Associates With Hyperinsulinemia in Impaired Glucose Tolerance
Theodorakis, M. J., Carlson, O. D., Muller, D. C., & Egan, J. M. (2004) · Diabetes Care · doi:10.2337/diacare.27.7.1692 · Cited by 56
Metabolic control in diabetic pregnancy
Persson, B., & Lunell, N. (1975) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(75)90580-3 · Cited by 55
The role of the Wnt signaling pathway in incretin hormone production and function
Chiang, Y., Ip, W., & Jin, T. (2012) · Frontiers in Physiology · doi:10.3389/fphys.2012.00273 · Cited by 59
Applications of dipeptidyl peptidase IV inhibitors in diabetes mellitus
McIntosh, C. H. S., Demuth, H., Kim, S.-J., Pospisilik, J. A., & Pederson, R. A. (2006) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2005.12.013 · Cited by 54
Glucagon-like Peptide-1 (GLP-1) and the Control of Glucose Metabolism in Mammals and Teleost Fish
Mojsov, S. (2000) · American Zoologist · doi:10.1668/0003-1569(2000)040[0246:glpgat]2.0.co;2 · Cited by 56
Gastric Inhibitory Polypeptide (GIP) Release and Incretin Effect after Oral Glucose in Obesity and after Jejunoileal Bypass
Lauritsen, K. B., Christensen, K. C., & Stokholm, K. H. (1980) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365528009181506 · Cited by 51
Stimulation of adenylate cyclase from isolated hepatocytes and Kupffer cells.
Wincek, T. J., Hupka, A. L., & Sweat, F. W. (1975) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)40753-9 · Cited by 51
Reactive hypoglycemia
Hofeldt, F. D. (1975) · Metabolism · doi:10.1016/0026-0495(75)90156-0 · Cited by 50

Authors: Unger, R. H.
Corresponding author: Unger, Roger H.
Venue: Archives of Internal Medicine
Publisher: American Medical Association (AMA)
Published: 1969-03-01
Volume: 123
Issue: 3
Pages: 261
ISSN: 0003-9926 (ISSN-L)
DOI: 10.1001/archinte.1969.00300130043007
OpenAlex: W2097717126
Cited by: 371
References: 20
Citations by year: 2025: 4 · 2024: 2 · 2023: 3 · 2022: 4 · 2021: 4 · 2020: 2 · 2019: 4 · 2018: 6 · 2017: 7 · 2016: 7 · 2015: 6 · 2014: 4 · 2013: 5 · 2012: 6
FWCI: 30.57
Type: journal article
Language: en
Open access: closed
Locations: Archives of Internal Medicine (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuropeptides and Animal Physiology
Keywords: enteroinsular axis, gut-brain axis, gastrointestinal hormones, insulin secretion, glucagon secretion, amino acids, glucose, gastrin, secretin, cholecystokinin, enteroendocrine cells
MeSH terms: Insulin Secretion, Amino Acids, Animals, Blood Glucose, Cholecystokinin, Dogs, Gastrins, Gastrointestinal Hormones, Glucagon, Glucose, Injections, Intravenous, Insulin, Intestinal Absorption, Pancreas, Secretin

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Entero-Insular Axis

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Citations

Cites

Cited by

Related

Metadata

Record

About these checks